Gene Query: MIF

Dataset Description Geneva Score
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 91.15
Studying the selectivity of a small molecule Synucleozid on transcriptome 73.44
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 72.77
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 68.73
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 67.47
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 63.1
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 58.2
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 58.2
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 56.98
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 53.54
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 53.13
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 53.13
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 49.36
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 49.09
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 46.86
RNA-seq of IL-4 stimulated human keratinocytes 45.96
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 44.23
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 44.23
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 40.02
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 39.61
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 38.5
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 38.3
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 38.27
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 37.15
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 36.99
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 36.99
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 36.97
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 36.93
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 36.92
Illumina Total RNA-seq in HeLa 36.55
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 36.43
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 36.02
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 34.32
Landscape of H3K4me3 in human CD19 cells 34.18
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 33.37
Targeting EZH2 in MYCN-amplified Neuroblastoma 33.37
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 33.29
The effect of PPARG inhibition on human angiomyolipoma cells 33.17
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 33.1
Differential gene expression of human melanoma cells [RNA-seq] 33.1
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 32.92
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 32.75
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 31.71
An RNA-centric dissection of host complexes controlling flavivirus infection 31.71
Gene expression changes due to PARP knockdown in human cells 31.01
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 29.9
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 29.9
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 29.47
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 29.22
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 28.97
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 28.36
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 28.32
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 28.28
Genome-wide functional assessment of enhancer activities in the human genome 27.64
RNA-sequencing of healthy human skeletal myocytes 26.69
RNA-seq of cells with TET1 knockout 26.56
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 25.8
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 25.71
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 25.46
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 25.45
NRDE2 negatively regulates nuclear exosome functions 25.35
Mitochondrial dsRNA triggers antiviral signalling in humans 25.09
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 24.7
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 24.42
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 24.42
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 24.25
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 24.24
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 24.16
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 23.77
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 23.42
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 23.16
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 23.07
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 23.06
Gene expression profiling of leukemia cells following asparagine depletion 22.74
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 22.71
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 22.71
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 22.41
Developmental stage specific chromosome architecture in human erythroid cells 22.41
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 22.36
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 22.28
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 22.13
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 22.09
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 22.0
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 22.0
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 21.71
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 21.63
Stem and effector CD8 T-cells from human cancers 21.6
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 21.41
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 21.37
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 21.31
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 21.21
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 21.17
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 21.0
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 20.95
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 20.34
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 20.13
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 20.12
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 20.06
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 19.86
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 19.68
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 19.53
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 19.11
Ectoderm specification of H1 human embryonic stem cells 18.84
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 18.83
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 18.54
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 18.53
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 18.47
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 18.1
RNA sequencing of primary human platelets and in vitro cell lines 17.61
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 17.56
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 17.5
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 17.46
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 17.32
TGF-β regulation of miRNA expression in pancreatic cancer 17.27
EP400 is required for Max and MCPyV mediated gene activation 17.27
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 17.22
Global analysis of enhancer targets: Mosaic-seq 17.15
The human blood-nerve barrier transcriptome 17.07
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 17.07
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 17.04
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 16.96
Global expression profiles in cardiac progenitor cells generated by ISX-9 16.96
SLAM-seq for K562 endogenous mRNA decay 16.76
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 16.76
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 16.76
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 16.68
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 16.65
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 16.65
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 16.65
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 16.61
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 16.55
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 16.51
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 16.43
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 16.42
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 16.42
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 16.4
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 16.4
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 16.35
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 16.35
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 16.18
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 16.1
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 16.04
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 15.88
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 15.88
Effect of FGF13 depletion on the H460 cell line 15.61
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 15.26
RNA splicing alteration on glioblastoma and normal neural stem cells 15.2
RNA m5C Methylation in breast cancer using MeRIP-Seq 15.14
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 15.11
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 15.02
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 15.02
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 14.99
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 14.83
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 14.83
RNA-seq of resting and activated CD4+ T cells +-JQ1 14.83
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 14.78
Molecular Mechanisms of Endothelial Hyperpermeability 14.73
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 14.7
Human cells contain natural double-stranded RNAs with potential regulatory capacity 14.63
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 14.59
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 14.58
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 14.58
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 14.57
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 14.54
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 14.47
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 14.18
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 14.17
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 14.14
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 14.1
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 14.09
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 14.06
Peptidomimetic blockade of MYB in acute myeloid leukemia 14.06
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 13.98
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 13.93
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 13.84
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 13.83
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 13.83
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 13.8
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 13.77
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 13.7
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 13.65
NKX2.2 13.56
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 13.56
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 13.54
Transcriptomic and gene ontology profiling of the human corneal cell types 13.48
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 13.44
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 13.43
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 13.41
Role of microRNAs in the interaction between Salmonella and the host cell 13.41
U1 snRNP telescripting regulates size-function stratified human genome 13.33
Effect of BB608 on Gene Expression in HNSCC Cell Line 13.2
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 13.19
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 13.17
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 13.17
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 12.91
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 12.86
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 12.83
Gene induction by the USP6 oncogene in response to interferon 12.8
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 12.8
Expression and functions of long noncoding RNAs during human T helper cell differentiation 12.77
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.64
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.64
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 12.57
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 12.54
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 12.53
Statins modulate endothelial transcriptional profile by inhibiting EZH2 12.42
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 12.37
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 12.31
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 12.31
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 12.25
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 12.08
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.97
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 11.97
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.95
High-throughput sequencing of PROMPT-enriched samples. 11.89
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 11.85
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 11.76
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 11.66
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 11.66
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 11.61
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 11.58
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 11.48
Evaluating pre-clinical models for studying NASH driven HCC. 11.46
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 11.46
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 11.45
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 11.38
Microprocessor mediates transcription termination in long noncoding microRNA genes 11.33
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 11.21
U2AF1 mutations alter splice site recognition in hematological malignancies 11.02
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 10.99
Investigate A2M treatment on human prostate cancer xenograft in mice 10.94
Investigate A2M treatment on human prostate cancer and mouse liver 10.94
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 10.9
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 10.9
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 10.88
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 10.88
RNA-sequencing in irradiated and normal A549 cells. 10.78
Landscape and variation of RNA secondary structure across the human transcriptome 10.78
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 10.72
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 10.71
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 10.64
Hepatocyte maturation 10.64
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 10.62
Expression profiling of etoposide-induced senescent cells 10.62
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 10.6
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 10.46
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 10.46
Modeling Familial Cancer with iPSC Approaches 10.44
Differential responses of human fetal brain neural stem cells to Zika virus infection 10.44
Single-cell analysis of human kidney organoids 10.41
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.38
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 10.33
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 10.24
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 10.24
circRNA profile in hypopharyngeal cancer 10.23
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 10.07
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.96
Reassessment of Exosome Composition 9.92
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.87
RNA transcriptome analysis during HSV-1 infection 9.75
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 9.7
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 9.69
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 9.49
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.45
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.45
Hepatitis C virus functionally sequesters miR-122 9.24
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.24
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 9.18
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 9.18
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 9.15
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.09
A map of gene expression in neutrophil-like cell lines 9.09
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 9.04
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.02
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 8.95
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 8.72
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.55
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.55
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 8.5
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 8.5
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 8.49
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 8.49
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 8.47
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 8.32
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 8.28
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 8.28
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 8.27
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 8.27
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 8.23
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 8.23
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 8.21
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 8.1
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 8.03
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 8.01
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 7.96
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 7.91
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 7.87
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 7.77
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.77
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 7.71
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 7.7
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.65
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.65
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 7.64
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 7.36
circNFIB suppresses lymphatic metastasis of pancreatic cancer 7.25
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 7.1
Global transcriptome analysis of WT versus HEB-/- hESCs 7.1
Alagille_Nodder 7.0
RNA Seq of Alagille liver biopsies 7.0
Transcription elongation regulates genome 3D structure 6.99
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.99
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 6.83
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 6.83
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.82
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 6.74
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.68
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.68
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 6.57
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 6.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.5
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.5
METTL3 and WTAP 6.38
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.27
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 6.19
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 6.1
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 6.09
BACH2 in human plasma cell fate decision 6.02
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.96
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 5.94
miR-93 Targets in Human Endothelial Cells 5.93
Identification of a LIF-responsive replication-competent human β cell 5.84
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 5.83
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 5.83
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 5.74
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.74
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.67
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.57
RNA editing in nascent RNA affects pre-mRNA splicing 5.55
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 5.54
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 5.54
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 5.46
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 5.42
Region-specific Innate Antiviral Responses of the Human Epididymis 5.41
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.34
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 5.27
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.23
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 5.13
DAOY-Notch1/Notch2 knockout: transcriptome comparison 5.11
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 5.04
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 5.02
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  4.95
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 4.95
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.94
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 4.92
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.9
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.88
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 4.81
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.81
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 4.79
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 4.79
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.78
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.71
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.64
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.63
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 4.63
HNF1 regulates critical functions of the human epididymis epithelium. 4.63
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 4.62
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.5
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.5
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.44
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 4.36
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.31
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 4.3
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 4.21
RNA-Seq from human ILC transitional populations 4.18
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 4.18
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.17
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 4.17
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.14
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 4.03
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.02
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.94
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.92
Zone dependent distinctive gene expression profile of the normal human liver tissue 3.83
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.82
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.82
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.8
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 3.79
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.78
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.77
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.77
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.74
Gene expression analysis of human adenomas. 3.69
Nutritional control of protein translation 3.69
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 3.65
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.63
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.56
Toxoplasma gondii infection of human retinal pigment epithelial cells 3.51
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.37
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.33
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.33
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.33
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.29
Regulation of hypoxia-inducible factor activity by ZMYND8 3.27
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.26
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.16
Macrophage Ad5f35 M2 Challenge 3.05
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 3.04
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.04
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 3.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.94
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.84
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 2.79
SRSF1 role in cellular gene expression and splicing 2.75
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 2.74
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.68
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.67
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.63
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.57
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.29
IMP3 regulated gene expression in breast cancer cells 2.24
Activity-dependent transcriptional changes in human neurons 2.24
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.12
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.1
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.1
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.95
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.92
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 1.89
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 1.89
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.88
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.88
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.88
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.85
Interaction between mitoNEET and NAF-1 in cancer cells 1.84
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.77
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 1.77
Androgen Receptor-regulated genes in prostate cancer cells 1.77
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.75
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.73
A single-cell transcriptome atlas of the human pancreas 1.71
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.59
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.59
RNA-seq data from human lymphoma cell lines 1.59
ChIP-seq and RNA-seq from human lymphoma cell lines 1.59
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.58
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.57
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.55
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.55
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.45
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.33
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.32
Changes in human endometrial gland transcriptome over the window of implantation 1.29
Transcriptome-wide modulation of splicing by the exon junction complex 1.26
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.16
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.15
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.15
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 1.06
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.04
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 0.97
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.95
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.95
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.91
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.85
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.84
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.82
The bromodomain protein BRD4 regulates splicing during heat shock 0.77
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.7
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 0.7
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 0.65
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.54
hESC neural differentiation 0.52
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.52
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.51
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.51
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.48
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.48
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.48
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.48
Impact on erythroid progenitor type on erythroid differntiation 0.47
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.46
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.46
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.46
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.42
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.4
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.36
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.35
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.35
RNA-seq data 0.31
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.29
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.24
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.17
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.12
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.12
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.12
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.11
Enhancer activation during EGF response 0.11
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.02
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation